Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...
Source: prnewswire.com